171 related articles for article (PubMed ID: 7282453)
1. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
Fodstad H; Pilbrant A; Schannong M; Strömberg S
Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
Fodstad H
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
[No Abstract] [Full Text] [Related]
4. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
Maurice-Williams RS; Gordon YB; Sykes A
J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
Schisano G; Franco A; Nina P; Papa ML; Iannuzzi M; De Biase R; Caldora M
J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
Fodstad H; Kok P; Algers G
Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.
Guggiari M; Dagreou F; Rivierez M; Mottet P; Gallais S; Philippon J; Viars P
Acta Neurochir (Wien); 1984; 73(1-2):25-33. PubMed ID: 6496196
[TBL] [Abstract][Full Text] [Related]
8. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
[TBL] [Abstract][Full Text] [Related]
9. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
Alvarez Garijo JA; Vilches JJ; Aznar JA
J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity in CSF of patients with SAH in the acute phase measured by a rapid method (correlation with t-AMCA concentration in CSF.
Nishimatsu T; Shibasaki T; Sasaki H; Nukui H
Neurol Med Chir (Tokyo); 1981 Jan; 21(1):85-93. PubMed ID: 6168953
[No Abstract] [Full Text] [Related]
11. Low-dose tranexamic acid combined with aprotinin in the pre-operative management of ruptured intracranial aneurysms.
Spallone A; Pastore FS; Rizzo A; Guidetti B
Neurochirurgia (Stuttg); 1987 Nov; 30(6):172-6. PubMed ID: 2447515
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
13. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
Steinmetz H; Grote E
Neurol Res; 1983; 5(4):59-65. PubMed ID: 6149487
[TBL] [Abstract][Full Text] [Related]
14. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.
Guidetti B; Spallone A
Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061
[TBL] [Abstract][Full Text] [Related]
15. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
Schisano G
Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytic treatment in subarachnoid haemorrhage: present state.
Fodstad H
Acta Neurochir (Wien); 1982; 63(1-4):233-44. PubMed ID: 7048863
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
Fodstad H; Forssell A; Liliequist B; Schannong M
Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
[TBL] [Abstract][Full Text] [Related]
19. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
Chandra B
Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products.
Sawaya R; Sonnino V; McLaurin RL; Perrotta G
J Neurosurg; 1983 May; 58(5):699-707. PubMed ID: 6834119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
